Ocrevus (ocrelizumab) appears to be safe and effective for children and adolescents with multiple sclerosis (MS), according to real-world data from Kuwait. After about 15 months of treatment, more than 90% of patients with pediatric-onset MS (POMS) remained free of relapses, and most also showed no new…

Among people in New Zealand, the proportion of individuals with multiple sclerosis (MS) — the disease’s prevalence, or how common it is — has grown by about one-third in recent decades, a new study found. In 2006, 72.4 of every 100,000 people who lived in the country had MS,…

I am not particularly hairy, but even having sparse and fine body hair pulled out by an adhesive is an unpleasant experience. During trauma training in a U.S. Army Special Forces medic course, we had to take turns pretending to be one another’s casualties, which involved a lot of tape…

People with multiple sclerosis (MS) who have chronic lower body pain show distinct changes in how they walk, including significantly slower gait speed, than those without pain, a study reports. Those with chronic lower body pain also took fewer and shorter steps, had longer step durations, and had…